"10.1371_journal.pone.0110316","plos one","2014-10-31T00:00:00Z","Fran√ßois Autelitano; Denis Loyaux; S√©bastien Roudi√®res; Catherine D√©on; Fr√©d√©rique Guette; Philippe Fabre; Qinggong Ping; Su Wang; Romane Auvergne; Vasudeo Badarinarayana; Michael Smith; Jean-Claude Guillemot; Steven A Goldman; Sridaran Natesan; Pascual Ferrara; Paul August","Sanofi-Aventis Recherche & D√©veloppement, Centre de Toulouse, Toulouse, France; ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America; Department of Neurology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York, United States of America; Sanofi US, Cambridge, Massachusetts, United States of America; Sanofi Tucson Research Center, Oro Valley, Arizona, United States of America","Conceived and designed the experiments: P. Ferrara SN MS PA SAG JCG FA VB. Performed the experiments: SW RA SR QP CD FG P. Fabre VB. Analyzed the data: FA PA DL. Contributed reagents/materials/analysis tools: SW RA SR QP CD FG P. Fabre VB. Contributed to the writing of the manuscript: FA PA.","The authors‚Äô have the following interests: One or more of the authors have an affiliation to Sanofi who supported in part this research study. This study was supported in part by Sanofi. Co-authors Fran√ßois Autelitano, Denis Loyaux, S√©bastien Roudi√®res, Catherine D√©on, Fr√©d√©rique Guette, Philippe Fabre, Jean-Claude Guillemot and Pascual Ferrara are employed by Sanofi-Aventis Recherche & D√©veloppement. Co-author Sridaran Natesan is employed by Sanofi US. Co-authors Vasudeo Badarinarayana, Michael Smith and Paul August are employed by Sanofi Tucson Research Center. There are no patents, products in development or marketed products to declare. This does not alter authors‚Äô adherence to all the PLoS ONE policies on sharing data and materials.","2014","10","Fran√ßois Autelitano","F√A",16,TRUE,1,7,3,NA,TRUE,TRUE,TRUE,5,"10;11;12;13;14",TRUE
